https://www.thegatewaypundit.com/2022/03/cdc-releases-international-data-risk-myocarditis-caused-mrna-covid-19-vaccines/
In a new update published on the CDC website
on February 22nd, scientists say prolonging the interval between the
first and second dose from six to eight weeks “may mitigate the risk of
myocarditis/pericarditis and improve vaccine effectiveness.”
The CDC said the relative risk for myocarditis caused by mRNA vaccine is higher in young males ages 12 to 39 years old.
According to the update, a 3 or 4-week interval continues to be the
recommended interval for people who are moderately to severely
immunocompromised, adults ages 65 years and older, and others who need
rapid protection due to increased concern about community transmission
or risk of severe disease.
Extending the interval between the first and second doses might reduce myocarditis risk.
CDC
released a new study examining international data and policies on
preferential recommendations of an mRNA vaccine product or extended
primary series intervals as they relate to myocarditis and/or
pericarditis. Below is the summary of findings in each country.
USA: Summary of Findings
Canada: Summary of findings
United Kingdom: Summary of findings
Nordic Countries: Nordic cohort, myocarditis results
Denmark: SARS-CoV-2 vaccination and myocarditis or myopericarditis: population-based cohort study
France and Germany: Summary of findings
According to the summary of findings, the risk of myocarditis may be higher for Moderna than the Pfizer vaccine.
The study concluded that myocarditis and pericarditis may be
associated with Moderna vs. Pfizer especially in males aged 18-29 years
old and also with shorter primary series intervals.
After billions of their test vaccines were given only now they are
saying to extend the interval between shots or you could face
myocarditis.
It’s a little too late for that now.
You can read the full report here.